Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.
In our age of technology, the immense scale of biological data is more than just a resource—it’s the new frontier for understanding complex molecular and cellular mechanisms. Bioinformatics plays a pivotal role in managing and deciphering this data, with the potential to transform research and improve lives. From disease research to new treatment development, bioinformatics empowers researchers to accelerate discoveries and bridge the gap from data to impactful results.
The challenge remains: enabling more researchers and clinicians to harness these powerful resources effectively. We are here to help simplify big data analysis and make advanced bioinformatics techniques accessible to everyone. By providing guidance and expert support, we ensure that navigating complex datasets is no longer a barrier but an opportunity for impactful research.
Learn more at https://omicslogic.com.
At Genentech we're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That's why we use cutting-edge science to create and deliver innovative medicines around the globe.
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients.
We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health.
Visit cytiva.com to learn more.
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. NEB is focused on strengthening alliances, enabling new technologies to impact market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. NEB is headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and subsidiaries located in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore, South Korea and the UK.
Please follow our community guidelines, you can find them here: https://www.neb.com/community-guidelines
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.
This Moderna page is not the appropriate place to report adverse events (side-effects ) for any products. If you are or someone you know is experiencing a side effects, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Beike Biotechnology is an industry leader in adult stem cell development. Beike provides umbilical cord derived stem cells to treatment facilities for treating presently incurable conditions. Here we will post videos of our partners, patients, and updates from Beike and the stem cell biotechnology world.
www.beikebiotech.com
www.stemcelltreatmentnow.com
Subscribe to learn more about how progress happens together.
Abcam is a global life science company enabling scientific breakthroughs by serving life scientists to achieve their mission, faster. We identify, develop, and provide high-quality biological reagents, protein tools and custom cell engineering to drive crucial research, drug discovery, diagnostic and therapeutic applications. Collaborating across the life science industry, our aim is that all life scientists will have access to the newest and best proteomic research tools and solutions. Our innovative products help accelerate the global understanding of biology and enable discoveries that positively impact society, including advances in human health, sustainable agriculture and environmental management.
To discover more, please visit https://www.abcam.com
AbbVie is a global biopharmaceutical company committed to creating medicines and solutions that put impact first — for patients, communities and our world. We focus on core therapeutic areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs: immunology, oncology, neuroscience, eye care, medical aesthetics and other specialty areas. This channel highlights patient stories, leadership voices, our scientific work and our culture.
Learn more about us at www.abbvie.com and follow @abbvie on Twitter, LinkedIn, Facebook or Instagram.
Learn about Cepheid, our technology, and our mission to improve healthcare here on our YouTube channel.
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com.
Cube Biotech is a privately held company based in Monheim, Germany. Cube Biotech was founded in 2012 by a group of experts in membrane protein biology and organic chemistry. With more than 40 years of experience shared among us, we provide: Excellence in membrane protein expression, purification, and crystallization. Expertise in synthesis of standard and tailor-made affinity matrices. High-quality products at reasonable pricing.
Hastalar için yenilikçi ilaçları keşfetmeye ve geliştirmeye kendini adamış araştırma odaklı global bir biyofarma şirketiyiz.
Misyonumuz, bugünün ciddi sağlık sorunlarını çözerken gelecekteki tedaviler için yenilikçi ilaçlar keşfetmeye ve sunmaya devam etmektir.
Odak Alanlarımız: İmmünoloji, Hematoloji Onkoloji, Göz Sağlığı, Nörolojik Bilimler, Spesifik Farma, Medikal Estetik
Amgen aprovecha lo mejor de la biología y la tecnología para luchar contra las enfermedades más graves del mundo, ya sean comunes, o raras, para hacer la vida de las personas más plena y duradera. Desde su nacimiento en 1980, Amgen ha contribuido a construir los fundamentos de la industria biomédica actual y sigue estando a la vanguardia de la innovación para ir más allá de lo que se conoce hoy.
¡Suscríbete y conócenos!
Puedes contactar con nosotros a través de https://www.amgen.es/sobre-amgen/contacto
AbbVie est une entreprise biopharmaceutique internationale axée sur la recherche. Sa mission : mettre à disposition son expertise, ses équipes et une approche unique de l'innovation pour développer des thérapies innovantes qui répondent à des maladies graves, invalidantes et complexes dans des aires thérapeutiques majeures : l’immunologie, l’ophtalmologie, l’oncologie, les neurosciences et la virologie, ainsi qu’en médecine esthétique avec les produits et services d’Allergan Aesthetics, une division AbbVie. Présent dans plus de 75 pays, le Groupe emploie près de 50 000 personnes dans le monde. Pour en savoir plus : www.abbvie.fr
A propos de la chaîne YouTube AbbVie France : https://goo.gl/6yFGKZ
FR-ABBV-230079 - 05/2023
Getein Biotech, Inc. (stock code:603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes analytical medical devices as well as a broad range of innovative diagnostic test kits. In July 2017, Getein Biotech got listed on the main board of the Shanghai Stock Exchange (SSE).
With great contribution of our advanced R&D center in 19-year continuous development, Getein Biotech has launched 8 technology platforms, including Point-Of-Care Testing, chemiluminescence, clinical chemistry, hematology, coagulation, molecular diagnostics, rehabilitation and quality control.
By now, Getein Biotech possesses more than 20 independent intellectual property products, covering multiple fields including cardiovascular diseases, kidney injury, diabetes, fertility, infectious diseases, cancer, etc.
Leader mondial des biotechnologies, Amgen utilise les ressources du vivant pour concevoir des médicaments innovants destinés à soigner des patients atteints de maladies graves. Cette approche repose sur des technologies de pointe, telles que la génétique humaine, qui permettent de caractériser les mécanismes moléculaires à l’origine des maladies. Amgen focalise ses recherches sur les pathologies pour lesquelles les besoins médicaux restent importants.
En France, Amgen se consacre à faire progresser la prise en charge du cancer, des maladies cardiovasculaires, inflammatoires et rénales. Au-delà du médicament, Amgen s’attache à développer des solutions d’optimisation de la prise en charge des patients.
Located in Shenzhen, China, Dymind Biotechnology Co, Ltd. is an international high-tech enterprise specialized in the R&D, manufacture, sales and service of medical devices and reagents in the field of IVD.
Since founded in 2013, Dymind has adhered to continuous innovation and customer orientation, which lead to a course of steady and sustainable growth. In the competition with domestic brands, we hold an increasing market share which ranks second in the hematology market. Nowadays, Dymind's products and services have been spread to over 140 counties and regions. With hich-standard and comprehensive joint detection solutions covering the fields of hematology, POCT, veterinary, coagulation and immunology, Dymind always takes responsibility of health care for all with innovative medical technologies.
AbbVie Deutschland auf YouTube
AbbVie ist ein globales, forschendes BioPharma-Unternehmen, das sich der Entwicklung innovativer Therapien für einige der komplexesten und schwerwiegendsten Erkrankungen der Welt verschrieben hat. Mission des Unternehmens ist es, mit seiner Expertise, seinen engagierten Mitarbeitern und seinem Innovationsanspruch die Behandlungsmöglichkeiten in vier Therapiegebieten deutlich zu verbessern: Immunologie, Onkologie, Virologie und Neurowissenschaften.
In mehr als 75 Ländern arbeiten AbbVie-Mitarbeiter jeden Tag daran, die Gesundheitsversorgung für Menschen auf der ganzen Welt voranzutreiben. In Deutschland ist AbbVie an seinem Hauptsitz in Wiesbaden und seinem Forschungs- und Produktionsstandort in Ludwigshafen vertreten. Insgesamt beschäftigt AbbVie Deutschland rund 2.800 Mitarbeiter.
Die Community Guidelines von AbbVie sind unten verlinkt.
Amgen erforscht, entwickelt, produziert und vertreibt innovative Therapien für Menschen. Seit 1980 gehört Amgen zu den Pionieren in der Biotechnologie und war eines der ersten Unternehmen, das die neuen Möglichkeiten der Wissenschaft erkannte, sichere und wirksame Arzneimittel aus dem Labor in die Herstellung und zu den Patienten zu bringen. Die Therapien von Amgen haben die medizinische Praxis verändert und Millionen von Menschen auf der ganzen Welt im Kampf gegen Krebs, Nierenleiden, rheumatoider Arthritis und andere schwere Erkrankungen unterstützt. Amgen verfügt über ein tiefes und breites Portfolio möglicher neuer Arzneimittel und ist ständig bestrebt, die Forschung voranzutreiben, um das Leben der Menschen entscheidend zu verbessern.
Besuchen Sie unsere Websites, um mehr über unsere bahnbrechenden Forschungen und bedeutenden Therapien zu erfahren.
Horizon Therapeutics is now part of Amgen. We encourage you to follow Amgen on YouTube at: https://www.youtube.com/@Amgen. The Horizon YouTube page is no longer active or monitored.
We are one of the most resilient biotech companies in Eastern Europe
We provide partners in 23 countries worldwide with Food, Feed, Bakery, and Alcohol Solutions to increase the value of life by implementing bioengineering technology into people's daily lives
This is the UK channel for AbbVie, a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. Our mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In the UK and more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
For more information about AbbVie in the UK, please visit us at www.abbvie.co.uk. Follow @abbvieuk on Twitter.
Our social media community guidelines here: http://www.abbvie.co.uk/privacy/home.html#8NZ5a8xk6a
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Legal Disclaimer
This YouTube account is owned by AMGEN AB (Sweden) and its branch offices AMGEN FILIAL AF AMGEN AKTIEBOLAG, SVERIGE (Denmark), AMGEN AB NORGE (Norway) and AMGEN AKTIEBOLAG, FILIAL I FINLAND, which hereby will be referred to as AMGEN Nordic. This AMGEN Nordic YouTube account is intended for audiences in Sweden, Denmark, Finland and Norway. The videos are published by the AMGEN Nordic Communications team. This AMGEN Nordic YouTube account aims to spread information that is non-product related. AMGEN Nordic is not responsible for any content posted by third parties in the related videos section. For further information about how Amgen is processing personal data please check the local Amgen websites in the links below.
En AbbVie llevamos más de 125 años mejorando la vida de las personas. Somos una compañía biofarmacéutica centrada en el paciente y en la innovación. Estamos especializados en el desarrollo de tratamientos avanzados para enfermedades complejas y graves.
Para más información sobre AbbVie, visita www.abbvie.es. Puedes seguirnos en Twitter, Instagram y LinkedIn. Revisa nuestras normas de uso aquí: https://www.abbvie.es/social-media.html
People. Passion. Possibilities.
Einen echten Unterschied im Leben von Menschen zu machen. Das ist der Anspruch von AbbVie. Das biopharmazeutische Unternehmen will die Gesundheit und Lebensqualität von Patienten stärken und entwickelt deshalb Lösungen für die global dringlichsten gesundheitlichen Herausforderungen. Weltweit arbeiten rund 50.000 Mitarbeiter:innen an einem Auftrag – das Leben der Patient:innen zu verbessern und die Gesellschaft positiv mitzugestalten. Wien ist ein zentraler Standort im Herzen Europas. Rund 150 AbbVie Mitarbeiter:innen arbeiten hier mit Fachwissen, Überzeugung und Leidenschaft an neuen Behandlungsmethoden. AbbVie setzt auf eine partnerschaftliche Zusammenarbeit mit den Akteuren im Gesundheitswesen. Um die Patienten zu unterstützen, arbeitet das Unternehmen mit Selbsthilfegruppen und Patienten-Organisationen zusammen.
Unsere YouTube-Guidelines sind unten verlinkt.
A AbbVie é uma companhia biofarmacêutica global, orientada para a investigação e desenvolvimento, empenhada no desenvolvimento de terapêuticas inovadoras avançadas que respondam a algumas das doenças mais complexas e graves a nível mundial. A missão da companhia é fazer uso da sua experiência, da dedicação dos seus colaboradores e da sua abordagem única à inovação para melhorar de forma significativa a oferta terapêutica em quatro áreas principais: imunologia, oncologia, virologia e neurociência. Os colaboradores da AbbVie trabalham diariamente em mais de 75 países para desenvolver soluções de saúde para pessoas em todo o mundo.
AbbVie är ett forskande biopharmaföretag som utvecklar innovativa behandlingar mot svåra sjukdomar, med målet att flytta fram gränsen för vad som är möjligt att uppnå med medicinsk behandling och förbättra livet för människor som påverkas av sjukdom. Våra fokusområden är immunologi, neurologi, onkologi, virologi och ögonsjukdomar. AbbVie finns i 175 länder och har cirka 50 000 medarbetare.
www.loop-biotech.com
@loopbiotech (instagram, linkedin, facebook)
JOIN THE MISSION
Loop Biotech - founded in 2020 by Hendrikx in the Netherlands - is the initiator and builder of the
world's first living coffin that enriches the earth. The company aims to restore balance with nature by
providing eco-friendly solutions for everyday products on the international scale, beginning with the
death-care industry. The Loop Living Cocoon™ is a groundbreaking, innovative and sustainable
alternative to the traditional coffin. Learn more at www.loop-biotech.com and join the mission to enrich nature!
Data as of 2025-03-29 